Multiple myeloma: Reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy courses

British Journal of Haematology

Volumn 99, Issue 3, 1997, Pages 685-691

  Omedè, Paola ^a,b   Tarella, Corrado ^a   Palumbo, Antonio ^a   Argentino, Chiara ^a   Caracciolo, Daniele ^a   Corradini, Paolo ^a   Dominietto, Alida ^a   Giaretta, Fulvia ^a   Ravaglia, Roberta ^a   Triolo, Roberta ^a   Triolo, Sabrina ^a   Pileri, Alessandro ^a   Boccadoro, Mario ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b Dipto di Med e Oncol Sperimentale Div Universitaria di Ematologia   (Italy)

Author keywords

High dose chemotherapy; Multiple myeloma; Plasma cells; Progenitor cells

Indexed keywords

CD38 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CYTOFLUOROMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9844238704     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4493259.x     Document Type: Article

References (42)

1. Anderson, K.C., Andersen, J., Soiffer, R., Freedman, A.S., Rabinowe, S.N., Robertson, M.J., Spector, N., Blake, K., Murray, C. Freeman, A., Coral, F., Marcus, K.C., Mauch, P., Nadler, L.M. & Ritz, J. (1993) Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood, 82, 2568-2576.
2. Anderson, K.C., Barut, B.A., Ritz, J., Freedman, A.S., Takvorian, T., Rabinowe, S.N., Soiffer, R., Heilin, L., Coral, F., Dear, K., Mauch, P. & Nadler, L.M. (1991) Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. Blood, 77, 712-720.
3. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Thyss, H., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
4. Barlogie, B., Jagannath, S., Vesole, D. & Tricot, G. (1995) Autologous and allogeneic transplants for multiple myeloma. Seminars in Hematology, 32, 31-44.
5. Barlogie, B., Jagannath, S., Vesole, D.H., Naucke, S., Cheson, B., Mattox, S., Bracy, D., Salmon, S., Jacobson, J., Crowley, J. & Tricot, G. (1997) Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood, 89, 789-793.
6. Boccadoro, M. & Pileri, A. (1997) Diagnosis, prognosis, and standard treatment of multiple myeloma. Hematology/Oncology Clinics of North America, 11, 111-131.
7. Brenner, M.K., Rill, D.R., Krance, R.A., Mirro, J., Anderson, W.F. & Ihle, J.N. (1995) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet, 341, 85-86.
8. Brugger, W., Bross, K.J., Glatt, M., Weber, F., Mertelsmann, R. & Kann, L. (1994a) Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood, 83, 636-640.
9. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, Ifosfamide, Carboplatin and Epirubicin. Blood, 84, 1421-1426.
10. Corradini, P., Voena, C., Astolfi, M., Ladetto, M., Tarella, C., Boccadoro, M. & Pileri, A. (1995) High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood, 85, 1596-1602.
11. Dreger, P., Kloss, M. Petersen, B., Haferlach, T. Loffler, H., Loeffler, M. & Schmitz, N. (1995) Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood, 86, 3970-3978.
12. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, 842-854.
13. + stem cells do not contain clonal myeloma cells. Blood, 86, 381-389.
14. Gazitt, Y., Tian, E., Barlogie, B., Reading, C.L., Vesole, D.H., Jagannath, S., Schnell, J., Hoffman, R. & Tricot, G. (1996) Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma alter treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood, 87, 805-811.
15. Gertz, M., Witzig, T., Pineda, A., Greipp, P., Kyle, R. & Litzow, M. (1995) Monoclonal plasma cells in the peripheral blood stem cell harvest of patients with multiple myeloma is associated with shortened relapse-free survival following transplantation. (Abstract). Blood, 86, (Suppl. 1), 207.
16. Gianni, A.M., Siena, S., Bregni, M., Tarella, C., Stern, A.C., Pileri, A. & Bonadonna, G. (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet, 8663, 580-584.
17. Gianni, A.M., Tarella, C., Bregni, M., Siena, S., Lombardi, F., Gandola, L., Caracciolo, D., Stern, A., Bonadonna, G., Boccadoro, M. & Pileri, A. (1994) High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma. Journal of Clinical Oncology, 12, 503-509.
18. Haas, R., Mohle, R., Fruhauf, S., Goldschmidt, H., Witt, B., Flentje, M., Wannenmacher, M. & Hunstein, W. (1994) Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83, 3787-5794.
19. Harada, H., Kawano, M.M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H. & Kuramoto, A. (1993) Phenotypic difference of normal plasma cells from mature myeloma cells. Blood, 81, 2658-2663.
20. Harada, Y., Kawano, M.M., Huang, N., Mahmoud, M.S., Lisukov, I.A., Mihara, K., Tsujimoto, T. & Kuramoto, A. (1996) Identification of early plasma cells in peripheral blood and their clinical significance. British Journal of Haematology, 92, 184-191.
21. Henry, J.M., Sykes, P.J., Brisco, M.J., To, L.B., Juttner, C.A. & Morley, A.A. (1996) Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests. British Journal of Haematology, 92, 614-619.
22. + cells to remove circulating tumor cells. Blood, 87, 1625-1634.
23. + cells for positive selection in newly diagnosed patients with myeloma and lymphoma. British Journal of Haematology, 92, 263-268.
24. Mariette, X., Fermand, J.P. & Brouet, J.C. (1994) Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplantation, 14, 47-50.
25. Moss, T.J., Cairo, M., Santana, V.M., Weinthal, J., Hurvitz, C. & Bostrom, M. (1994) Clonogenic circulating BM cells: implications regarding peripheral stem cell transplantation. Blood, 83, 3085-3089.
26. Omedè, P., Boccadoro, M., Fusaro, A., Gallone, G. & Pileri, A. (1993) Multiple myeloma: 'early' plasma cell phenotype identities patients with aggressive biological and clinical characteristics. British Journal of Haematology, 85, 504-513.
27. Palumbo, A., Pileri, A., Triolo, S., Omedè, P., Bruno, B., Ciravegna, G., Galliano, M., Frieri, R. & Boccadoro, M. (1997) Multicyclic, dose-intensive chemotherapy supported by hemopoietic progenitors in refractory myeloma patients. Bone Marrow Transplantation, 19, 23-29.
28. San Miguel, J.F., Garcia-Sanz, R., Gonzales, M., Moro, M.J., Hernandez, J.M., Ortega, F., Borrego, D., Carnero, M., Casanova, F., Jimenez, R., Portero, J.A. & Orfao, A. (1995) A new staging system for multiple myeloma based on the number of S-phase plasma cells. Blood, 85, 448-455.
29. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood, 86, 390-397.
30. Shpall, E.J. & Jones, R.B. (1994) Release of tumor cells from bone marrow. Blood, 83, 623-625.
31. Shpall, E.J., Jones, R.B., Bearman, S.I., Franklin, W.A., Archer, P.G., Curiel, T., Bitter, M., Claman, H.N., Stemmer, S.M., Purdy, M., Myers, S.E., Hami, L., Taffs, S., Heimfeld, S., Hallagan, J. & Berenson, R.J. (1994) Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. Journal of Clinical Oncology, 12, 28-36.
32. Siena, S., Bregni, M., Brando, B., Celli, N., Ravagnani, F., Gandola, L., Stern, A.C., Lansdorp, P.M., Bonadonna, G. & Gianni, A.M. (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77, 400-409.
33. Tarella, C., Benedetti, G., Caracciolo, D., Castellino, C., Cherasco, C., Bondesan, P., Omedè, P., Ruggieri, D., Gianni, A.M. & Pileri, A. (1995a) Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF. British Journal of Haematology, 91, 535-543.
34. Tarella, C., Caracciolo, D., Gavarotti, P., Bondesan, P., Cherasco, C., Omedè, P., Bregni, M., Siena, S., Gianni, A.M. & Pileri, A. (1995b) Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplantation, 16, 223-228.
35. Terstappen, L.W.M.M., Johnsen, S., Segers-Nolten, I.M.J. & Loken, M.R. (1990) Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood, 76, 1739-1747.
36. Tricot, G., Jagannath, S., Vesole, D., Nelson, J., Tindle, S., Miller, L., Cheson, B., Crowley, J. & Barlogie, B. (1995) Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood, 85, 588-596.
37. Vescio, R.A., Han, E.J., Schiller, G.J., Lee, J.C., Wu, C.H., Cao, J., Shin, J., Kim, A., Lichtenstein, A.K. & Berenson, J.R. (1996) Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Transplantation, 18, 103-110.
38. Vesole, D.H., Tricot, G., Jagannath, S., Desikan, K.R., Siegel, D., Bracy, D., Miller, L., Cheson, B., Crowley, J. & Barlogie, B. (1996) Autotransplants in multiple myeloma: what have we learned? Blood, 88, 838-847.
39. Weaver, C.H., Schwartzberg, L., Li, W., Hazelton, B. & West, W. (1996) High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease. Bone Marrow Transplantation, 17, 715-721.
40. Wijdenes, J., Vooijs, W.C., Clement, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R.X., Klein, B. & Dore, J.M. (1996) A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1 British Journal of Haematology, 94, 318-323.
41. Witzig, T.E., Kimlinger, T.K., Ahmann, G.J., Katzmann, J.A. & Greipp, P.R. (1996) Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry, 26, 113-120.
42. Zwicky, C.S., Maddocks, A.B., Andersen, N. & Gribben, J.G. (1996) Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood, 88, 3314-3322.